Why Haemonetics is on investors’ radar Haemonetics (HAE) has drawn fresh attention after recent trading left the shares about 17% lower over the past month, even as the stock shows a roughly 33% gain ...
Haemonetics will shell out up to 185 million euros ($216 million) to acquire Vivasure Medical, a Galway, Ireland-based medtech that makes arterial closure devices. Boston-based Haemonetics, which is ...
Medical Device Network on MSN

Haemonetics acquires Ireland-based Vivasure

The ELITE arterial study demonstrated ease of use for Vivasure's PerQseal Elite with no need for pre-close.
Riverwater Partners, an investment management company, released its “Sustainable Value Strategy” Q4 2025 investor letter. A ...
Loomis Sayles, an investment management company, released its “Small Cap Value Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. US equities delivered strong ...
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - specialty stocks, including Haemonetics (NYSE:HAE) and its peers. The medical devices industry ...
Haemonetics (NYSE:HAE) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...
BOSTON, June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched a ...
BOSTON, Nov. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2026, which ended September 27, 2025, are available on the ...
Haemonetics is dropping at least $160 million to acquire the maker of a system designed to cool down and protect the esophagus from errant damage during cardiac ablation procedures aimed at ...
(RTTNews) - Haemonetics Corp. (HAE) reported third-quarter adjusted profit per share of $0.84 compared to $0.81, prior year. On average, eight analysts polled by Thomson Reuters expected the company ...